• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ann Clin Microbiol Antimicrob . Contrasting SARS-CoV-2 RNA copies and clinical symptoms in a large cohort of Colombian patients during the first wa

tetano

Editor, Senior Moderator
Ann Clin Microbiol Antimicrob


. 2021 May 24;20(1):39.
doi: 10.1186/s12941-021-00445-8.
Contrasting SARS-CoV-2 RNA copies and clinical symptoms in a large cohort of Colombian patients during the first wave of the COVID-19 pandemic


Santiago A Quiroga[SUP] 1 2 [/SUP], Carolina Hernández[SUP] 1 [/SUP], Sergio Castañeda[SUP] 1 [/SUP], Paula Jimenez[SUP] 1 [/SUP], Laura Vega[SUP] 1 [/SUP], Marcela Gomez[SUP] 1 [/SUP], David Martinez[SUP] 1 [/SUP], Nathalia Ballesteros[SUP] 1 [/SUP], Marina Muñoz[SUP] 1 [/SUP], Claudia Cifuentes[SUP] 3 [/SUP], Nathalia Sierra[SUP] 3 [/SUP], Carolina Flórez[SUP] 4 [/SUP], Alberto Paniz-Mondolfi[SUP] 5 6 [/SUP], Juan David Ramírez[SUP] 7 [/SUP]



Affiliations

Abstract

Background: There is limited and controverting evidence looking at possible associations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA copies and patient variables in large cohorts of symptomatic and asymptomatic patients.
Methods: We studied 2275 symptomatic and asymptomatic patients from Colombia with coronavirus disease 2019 (COVID-19) and analyzed the associations between RT-PCR cycle threshold (Ct) value with gender, age, comorbidities, symptomatology, and disease severity.
Results: 15.4 % of the samples (n = 428) reported at least one comorbidity. There were 2011 symptomatic cases (72.4 %), being the most common reported symptom cough (57.2 %, n = 1586). Respiratory distress was present in 21.4 % of patients (n = 595), and 435 patients (15.6 %) required hospital admission. We observed that patients with no prior medical history harbored higher RNA copies than patients with comorbidities (p = 0.02). No significant differences in RNA copies were observed between symptomatic and asymptomatic patients (p = 0.82). Strong correlations were detected between Ct values and the presence of odynophagia (p = 0.03), diarrhea (p = 0.04), and headache (p = 0.0008). An inverse association was found between RNA copy number and markers of disease severity, namely, respiratory distress (P < 0.0001) and hospitalization requirement (P < 0.0001).
Conclusions: SARS-CoV-2 RT-PCR cycle thresholds reveal strong associations with a prior medical history, specific symptomatology, and disease severity markers. Further research controlling potential confounding variables needs to be conducted to evaluate the nature and usefulness of these associations in managing COVID-19 patients.

Keywords: COVID-19; Clinical symptoms; Comorbidities; Ct; RT-PCR; SARS-CoV-2.
 
Back
Top Bottom